Francisco Pasquel, MD, MPH
Emory University School of Medicine, Atlanta, Georgia

Francisco J. Pasquel, M.D., M.P.H, is an endocrinologist and epidemiologist with expertise in metabolism and diabetes technology. His research is partially funded by NIH and industry to study metabolism under stress conditions in high-risk patients, using bioinformatics (systems biology – omics) and continuous glucose monitoring (CGM) technology. Current research efforts focus on the use of remote monitoring and care with diabetes technologies (CGM and artificial pancreas) in different populations with diabetes, as well as the development of digital health solutions to improve care in patients with diabetes. Dr. Pasquel has also facilitated the implementation of diabetes technologies in the hospital to care for patients with COVID-19 and in an inner-city hospital clinic to improve the care of historically underserved populations. He serves as co-director for the NIH funded Regional Core (Technologies Advancing Translation and Equity) of the Georgia Center for Diabetes Translation Research (GCDTR). This Core is focused on advancing the availability, accessibility, and usability of key technologies that promote equitable and cost-effective diabetes prevention and management across partner institutions in the region (Florida, Georgia, and Tennessee).